↓ Skip to main content

Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults

Overview of attention for article published in BMC Cancer, October 2009
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
126 Dimensions

Readers on

mendeley
107 Mendeley